S Salim*, A Bouayad, A Mejait, G Alami, SM Abkari, A Ibrahimi and N Lahmidani
Hepato-Gastroenterology Department, Hassan II University Hospital, Fez, Morocco
*Corresponding Author: S Salim, Hepato-Gastroenterology Department, Hassan II University Hospital, Fez, Morocco.
Received: April 08, 2024; Published: April 26, 2024
Splenic abscess is an infectious collection arising from hematogenous or contiguous infections. It is a rare condition, predominantly affecting males and immunocompromised individuals. Currently, there is no consensus regarding the disease's management, including microbiological diagnosis and treatment. The preferred imaging test remains the CT scan, which exhibits excellent sensitivity (95%) and specificity (92%) [1]. It can also facilitate diagnostic punctures. Microbiological diagnosis relies on positive blood cultures, found in 24% to 80% of cases. Abscesses can complicate various immunosuppressive conditions. Diagnosis is often delayed due to clinical and biological presentations mimicking a relapse of the primary pathology [2].
We present the case of a 75-year-old woman diagnosed with ischemic heart disease in 2021 under treatment; the patient was recently diagnosed with primary biliary cholangitis (PBC) in March 2023, leading to the initiation of ursodeoxycholic acid (UDCA) at a dose of 13 mg/kg, resulting in significant clinical and biochemical improvement; The patient presented with a febrile syndrome, four months after the diagnosis of PBC; after all the necessary biological tests and additional examinations ; the diagnosis of a splenic abscess was confirmed, the patient was put on antibiotic therapy with good clinical and biological improvement.
Keywords: Primary Biliary Cholangitis (PBC);
Citation: S Salim., et al. “Case Report: Splenic Abscess complicating a Primary Biliary Cholangitis (PBC) - A Rare Clinical presentation". Acta Scientific Gastrointestinal Disorders 7.5 (2024): 13-16.
Copyright: © 2024 S Salim., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.